These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 19162218)
21. Editorial: Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning. de Almeida TF; Cunha-Junior EF; Wanderley JLM; Pacheco JDS; Pinto-da-Silva LH; Andrade-Neto VV; Chaves SP Front Cell Infect Microbiol; 2024; 14():1384244. PubMed ID: 38544526 [No Abstract] [Full Text] [Related]
25. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
26. The immunoproteasome: a novel drug target for autoimmune diseases. Basler M; Mundt S; Bitzer A; Schmidt C; Groettrup M Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S74-9. PubMed ID: 26458097 [TBL] [Abstract][Full Text] [Related]
27. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment. Murphy G; Lisnevskaia L; Isenberg D Lancet; 2013 Aug; 382(9894):809-18. PubMed ID: 23972423 [TBL] [Abstract][Full Text] [Related]
28. Application of Combination High-Throughput Phenotypic Screening and Target Identification Methods for the Discovery of Natural Product-Based Combination Drugs. Isgut M; Rao M; Yang C; Subrahmanyam V; Rida PCG; Aneja R Med Res Rev; 2018 Mar; 38(2):504-524. PubMed ID: 28510271 [TBL] [Abstract][Full Text] [Related]
29. Biologics: a new approach needed? Foster KA Drug Discov Today; 2010 Feb; 15(3-4):81-3. PubMed ID: 19778630 [No Abstract] [Full Text] [Related]
30. [Immune-pharmacology study on the immunoregulatory effects of Dabuyin Wan in autoimmune mice induced by Campylobacter jejuni]. Wang Y; Zhao Y Zhong Yao Cai; 2007 May; 30(5):567-70. PubMed ID: 17727064 [TBL] [Abstract][Full Text] [Related]
31. Pediatric psoriasis: updates in biologic therapies. Sukhatme SV; Gottlieb AB Dermatol Ther; 2009; 22(1):34-9. PubMed ID: 19222515 [TBL] [Abstract][Full Text] [Related]
32. Updates in the field of autoimmune pancreatitis: a clinical guide. de Pretis N; Amodio A; Frulloni L Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):705-709. PubMed ID: 29923430 [TBL] [Abstract][Full Text] [Related]
33. Safety assessment of immunomodulatory biologics: the promise and challenges of regulatory T-cell modulation. Ponce RA J Immunotoxicol; 2011; 8(4):389-97. PubMed ID: 21913866 [TBL] [Abstract][Full Text] [Related]
34. Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions. Bays AM; Gardner G Med Clin North Am; 2016 Jul; 100(4):719-31. PubMed ID: 27235612 [TBL] [Abstract][Full Text] [Related]
35. T cell factor 1: A master regulator of the T cell response in disease. Escobar G; Mangani D; Anderson AC Sci Immunol; 2020 Nov; 5(53):. PubMed ID: 33158974 [TBL] [Abstract][Full Text] [Related]
38. Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry). Pérez-De-Lis M; Retamozo S; Flores-Chávez A; Kostov B; Perez-Alvarez R; Brito-Zerón P; Ramos-Casals M Expert Opin Drug Saf; 2017 Nov; 16(11):1255-1271. PubMed ID: 28854831 [TBL] [Abstract][Full Text] [Related]
39. Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease. Bach JF C R Biol; 2006 Apr; 329(4):260-2. PubMed ID: 16644496 [TBL] [Abstract][Full Text] [Related]
40. Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases. Ulivieri C; Baldari CT Pharmacol Res; 2014 Oct; 88():41-52. PubMed ID: 24657239 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]